| Product Code: ETC8531917 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the Netherlands continued to rely on imports of aripiprazole, with key suppliers including the USA, China, South Korea, Germany, and the UK. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a moderate level, indicating a competitive market environment. However, the compound annual growth rate (CAGR) for the period 2020-2024 was negative at -9.09%, with a slight improvement in the growth rate from 2023 to 2024 at -7.39%. These trends suggest a challenging market for aripiprazole imports in the Netherlands, with potential opportunities for strategic adjustments to drive growth.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Aripiprazole Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Aripiprazole Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Aripiprazole Market - Industry Life Cycle |
3.4 Netherlands Aripiprazole Market - Porter's Five Forces |
3.5 Netherlands Aripiprazole Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Aripiprazole Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Aripiprazole Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Netherlands Aripiprazole Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Netherlands Aripiprazole Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Netherlands Aripiprazole Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Aripiprazole Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health disorders in the Netherlands. |
4.2.2 Growing prevalence of schizophrenia and bipolar disorder in the country. |
4.2.3 Favorable government initiatives and policies supporting mental health treatment. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in the Netherlands. |
4.3.2 Intense competition from generic drug manufacturers. |
4.3.3 High costs associated with aripiprazole treatment. |
5 Netherlands Aripiprazole Market Trends |
6 Netherlands Aripiprazole Market, By Types |
6.1 Netherlands Aripiprazole Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Aripiprazole Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Netherlands Aripiprazole Market Revenues & Volume, By Antipsychotics, 2021- 2031F |
6.1.4 Netherlands Aripiprazole Market Revenues & Volume, By Antimanic Agents, 2021- 2031F |
6.2 Netherlands Aripiprazole Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Aripiprazole Market Revenues & Volume, By Major Depressive Disorders, 2021- 2031F |
6.2.3 Netherlands Aripiprazole Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.2.4 Netherlands Aripiprazole Market Revenues & Volume, By Bipolar Mania, 2021- 2031F |
6.2.5 Netherlands Aripiprazole Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Aripiprazole Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Aripiprazole Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Netherlands Aripiprazole Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Netherlands Aripiprazole Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Aripiprazole Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.3 Netherlands Aripiprazole Market Revenues & Volume, By Orally Disintegrating Tablets, 2021- 2031F |
6.4.4 Netherlands Aripiprazole Market Revenues & Volume, By Oral Solution, 2021- 2031F |
6.4.5 Netherlands Aripiprazole Market Revenues & Volume, By Injection, 2021- 2031F |
6.5 Netherlands Aripiprazole Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Aripiprazole Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Netherlands Aripiprazole Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Netherlands Aripiprazole Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Netherlands Aripiprazole Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Aripiprazole Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Netherlands Aripiprazole Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Netherlands Aripiprazole Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Netherlands Aripiprazole Market Import-Export Trade Statistics |
7.1 Netherlands Aripiprazole Market Export to Major Countries |
7.2 Netherlands Aripiprazole Market Imports from Major Countries |
8 Netherlands Aripiprazole Market Key Performance Indicators |
8.1 Patient adherence rates to aripiprazole medication. |
8.2 Number of psychiatrists prescribing aripiprazole in the Netherlands. |
8.3 Rate of new product developments and innovations in the aripiprazole market. |
9 Netherlands Aripiprazole Market - Opportunity Assessment |
9.1 Netherlands Aripiprazole Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Aripiprazole Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Aripiprazole Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Netherlands Aripiprazole Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Netherlands Aripiprazole Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Netherlands Aripiprazole Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Aripiprazole Market - Competitive Landscape |
10.1 Netherlands Aripiprazole Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Aripiprazole Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here